Use and description |
Letrozole is approved to be used alone or with other drugs to treat: Breast cancer in postmenopausal women who have any of the following types of breast cancer-- Early-stage, hormone receptor–positive (HR+) breast cancer in women who have already received other treatment. |
Physical Characters and Index |
Product Name:Letrozole CAS:112809-51-5 Molecular Formula:C17H11N5 Molecular Weight:285.3 Appearance:White to off-white powder. Melting point:181-183°C Boiling point:563.5±60.0 °C(Predicted) Storage conditions:2-8°C |